TearSolutions, Inc.
Charlottesville, VA · Founded 2013 · CIK 0001611687 · Biotech · Private
Lacripep, a proprietary peptide therapeutic for ocular surface disease
tearsolutions.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $36M
- 11 Form D · Nov 2025
- 11 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 0 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2013201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $390,000 | |
| Private capital raised | Form D · SEC | $500,000 | |
| Private capital raised | Form D · SEC | $1,080,346 | |
| Private capital raised | Form D · SEC | $8,056,619 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $4,042,825 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $885,421 | |
| Private capital raised | Form D · SEC | $1,499,595 | |
| Private capital raised | Form D · SEC | $5,624,634 | |
| Private capital raised | Form D · SEC | $390,000 | |
| Private capital raised | Form D · SEC | $12,709,989 | |
| Private capital raised | Form D · SEC | $517,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1872 | Oncolix, Inc. | — | $8.9M |
| 1873 | COURAGE THERAPEUTICS INC | — | $4.5M |
| 1874 | Factor Holdings LLC | — | $25K |
| 1875 | TearSolutions, Inc. | — | $36M |
| 1876 | Optimvia, LLC | — | $75K |
| 1877 | Addex Therapeutics Ltd. | — | $14M |
| 1878 | STEMBIOSYS, INC. | — | $3.4M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Louis AlpernDirector
- Anil AsraniDirector · Executive Officer
- Jens BiertumpelDirector
- Leonard BorrmannDirector
- Michelle CarpenterExecutive Officer
- Alexey ChernushkinDirector
- Robert DempseyDirector · Executive Officer
- Konstantine DrakonakisDirector
- Thomas GadekDirector · Executive Officer
- Tom GadekDirector · Executive Officer
- Laurie GordonExecutive Officer
- Bruce KuperDirector
- Bruce KupperDirector
- Gordon LaurieDirector · Executive Officer · Promoter
- Mark LoganDirector · Executive Officer · Promoter
- John MooreExecutive Officer
- Marc OdrichExecutive Officer
- James RameyDirector
- Colin RolphExecutive Officer
- Amir ShojaeiDirector
- Mac ThompsonExecutive Officer
- William Thompson, Jr.Executive Officer
- W. McIlwaine Thompson, Jr.Executive Officer
- Alexey VinogradovDirector
Patents
- Stable Peptide Compositions And Methods Of Use Thereof For Treatment Of Moderate/severe Dry Eye-related Ocular Symptomsapplication
- Stable Peptide Compositions And Methods Of Use Thereof For Treatment Of Moderate/severe Dry Eye-related Ocular Symptomsapplication
- Stable Peptide Compositions And Methods Of Use Thereof For Treatment Of Moderate/severe Dry Eye-related Ocular Symptomsapplication
- Stable Peptide Compositions And Methods Of Use Thereof For Treatment Of Moderate/severe Dry Eye-related Ocular Symptomsapplication
- Constrained Salts Of Peptidesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.